Collectively, these data also support that SPRYD7 upregulation in CRC metastasis provokes the dysregulation of proteins associated with angiogenesis, inflammation, and cancer, contributing to the progression and aggressiveness of the observed phenotypes in CRC cells in vitro and in vivo, with enhanced liver homing and tumor growth. Here, SPRYD7 is linked to cancer.